Contineum Therapeutics files for IPO

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today we ponder the vast open spaces of Boston’s unused life sciences labs, see a new biopharma IPO in the works, and expect a label expansion for some CAR-T blood cancer therapies.

Read the rest…

Read Original Article: Contineum Therapeutics files for IPO »

About The Author